☰

Malika Hamdane - Publications

Affiliations: 
University Lille 1, Villeneuve-d'Ascq, Hauts-de-France, France 
Tree Info Similar researchers PubMed Report error

52 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 da Costa PJ, Hamdane M, Buée L, Martin F. Tau mRNA Metabolism in Neurodegenerative Diseases: A Tangle Journey. Biomedicines. 10. PMID 35203451 DOI: 10.3390/biomedicines10020241  0.365
2019 Carvalho K, Faivre E, Pietrowski MJ, Marques X, Gomez-Murcia V, Deleau A, Huin V, Hansen JN, Kozlov S, Danis C, Temido-Ferreira M, Coelho JE, Mériaux C, Eddarkaoui S, Gras SL, ... ... Hamdane M, et al. Exacerbation of C1q dysregulation, synaptic loss and memory deficits in tau pathology linked to neuronal adenosine A2A receptor. Brain : a Journal of Neurology. PMID 31599329 DOI: 10.1093/Brain/Awz288  0.318
2019 Sergeant N, Vingtdeux V, Eddarkaoui S, Gay M, Evrard C, Le Fur N, Laurent C, Caillierez R, Obriot H, Larchanché PE, Farce A, Coevoet M, Carato P, Kouach M, Descat A, ... ... Hamdane M, et al. New piperazine multi-effect drugs prevent neurofibrillary degeneration and amyloid deposition, and preserve memory in animal models of Alzheimer's disease. Neurobiology of Disease. PMID 30928644 DOI: 10.1016/J.Nbd.2019.03.028  0.355
2017 Marciniak E, Leboucher A, Caron E, Ahmed T, Tailleux A, Dumont J, Issad T, Gerhardt E, Pagesy P, Vileno M, Bournonville C, Hamdane M, Bantubungi K, Lancel S, Demeyer D, et al. Tau deletion promotes brain insulin resistance. The Journal of Experimental Medicine. PMID 28652303 DOI: 10.1084/Jem.20161731  0.413
2015 Derisbourg M, Leghay C, Chiappetta G, Fernandez-Gomez FJ, Laurent C, Demeyer D, Carrier S, Buée-Scherrer V, Blum D, Vinh J, Sergeant N, Verdier Y, Buée L, Hamdane M. Role of the Tau N-terminal region in microtubule stabilization revealed by new endogenous truncated forms. Scientific Reports. 5: 9659. PMID 25974414 DOI: 10.1038/Srep09659  0.473
2015 Giustiniani J, Guillemeau K, Dounane O, Sardin E, Huvent I, Schmitt A, Hamdane M, Buée L, Landrieu I, Lippens G, Baulieu EE, Chambraud B. The FK506-binding protein FKBP52 in vitro induces aggregation of truncated Tau forms with prion-like behavior. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 25888602 DOI: 10.1096/Fj.14-268243  0.705
2015 Melnyk P, Vingtdeux V, Burlet S, Eddarkaoui S, Grosjean ME, Larchanché PE, Hochart G, Sergheraert C, Estrella C, Barrier M, Poix V, Plancq P, Lannoo C, Hamdane M, Delacourte A, et al. Chloroquine and chloroquinoline derivatives as models for the design of modulators of amyloid Peptide precursor metabolism. Acs Chemical Neuroscience. 6: 559-69. PMID 25611616 DOI: 10.1021/Cn5003013  0.674
2014 Laurent C, Burnouf S, Ferry B, Batalha VL, Coelho JE, Baqi Y, Malik E, Mariciniak E, Parrot S, Van der Jeugd A, Faivre E, Flaten V, Ledent C, D'Hooge R, Sergeant N, ... Hamdane M, et al. A2A adenosine receptor deletion is protective in a mouse model of Tauopathy. Molecular Psychiatry. PMID 25450226 DOI: 10.1038/Mp.2014.151  0.426
2014 Laurent C, Eddarkaoui S, Derisbourg M, Leboucher A, Demeyer D, Carrier S, Schneider M, Hamdane M, Müller CE, Buée L, Blum D. Beneficial effects of caffeine in a transgenic model of Alzheimer's disease-like tau pathology. Neurobiology of Aging. 35: 2079-90. PMID 24780254 DOI: 10.1016/J.Neurobiolaging.2014.03.027  0.451
2014 Fernandez-Gomez FJ, Jumeau F, Derisbourg M, Burnouf S, Tran H, Eddarkaoui S, Obriot H, Dutoit-Lefevre V, Deramecourt V, Mitchell V, Lefranc D, Hamdane M, Blum D, Buée L, Buée-Scherrer V, et al. Consensus brain-derived protein, extraction protocol for the study of human and murine brain proteome using both 2D-DIGE and mini 2DE immunoblotting. Journal of Visualized Experiments : Jove. PMID 24747743 DOI: 10.3791/51339  0.36
2014 Charton J, Gauriot M, Guo Q, Hennuyer N, Marechal X, Dumont J, Hamdane M, Pottiez V, Landry V, Sperandio O, Flipo M, Buee L, Staels B, Leroux F, Tang WJ, et al. Imidazole-derived 2-[N-carbamoylmethyl-alkylamino]acetic acids, substrate-dependent modulators of insulin-degrading enzyme in amyloid-β hydrolysis. European Journal of Medicinal Chemistry. 79: 184-93. PMID 24735644 DOI: 10.1016/J.Ejmech.2014.04.009  0.34
2014 Flaten V, Laurent C, Coelho JE, Sandau U, Batalha VL, Burnouf S, Hamdane M, Humez S, Boison D, Lopes LV, Buée L, Blum D. From epidemiology to pathophysiology: what about caffeine in Alzheimer's disease? Biochemical Society Transactions. 42: 587-92. PMID 24646282 DOI: 10.1042/Bst20130229  0.386
2014 Bouillez A, Gnemmi V, Gaudelot K, Hémon B, Ringot B, Pottier N, Glowacki F, Butruille C, Cauffiez C, Hamdane M, Sergeant N, Van Seuningen I, Leroy X, Aubert S, Perrais M. MUC1-C nuclear localization drives invasiveness of renal cancer cells through a sheddase/gamma secretase dependent pathway. Oncotarget. 5: 754-63. PMID 24504508 DOI: 10.18632/Oncotarget.1768  0.302
2013 Van der Jeugd A, Vermaercke B, Derisbourg M, Lo AC, Hamdane M, Blum D, Buée L, D'Hooge R. Progressive age-related cognitive decline in tau mice. Journal of Alzheimer's Disease : Jad. 37: 777-88. PMID 23948912 DOI: 10.3233/Jad-130110  0.355
2013 Chapuis J, Hansmannel F, Gistelinck M, Mounier A, Van Cauwenberghe C, Kolen KV, Geller F, Sottejeau Y, Harold D, Dourlen P, Grenier-Boley B, Kamatani Y, Delepine B, Demiautte F, Zelenika D, ... ... Hamdane M, et al. Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology. Molecular Psychiatry. 18: 1225-34. PMID 23399914 DOI: 10.1038/Mp.2013.1  0.325
2013 Leboucher A, Laurent C, Fernandez-Gomez FJ, Burnouf S, Troquier L, Eddarkaoui S, Demeyer D, Caillierez R, Zommer N, Vallez E, Bantubungi K, Breton C, Pigny P, Buée-Scherrer V, Staels B, ... Hamdane M, et al. Detrimental effects of diet-induced obesity on τ pathology are independent of insulin resistance in τ transgenic mice. Diabetes. 62: 1681-8. PMID 23250356 DOI: 10.2337/Db12-0866  0.31
2013 Burnouf S, Martire A, Derisbourg M, Laurent C, Belarbi K, Leboucher A, Fernandez-Gomez FJ, Troquier L, Eddarkaoui S, Grosjean ME, Demeyer D, Muhr-Tailleux A, Buisson A, Sergeant N, Hamdane M, et al. NMDA receptor dysfunction contributes to impaired brain-derived neurotrophic factor-induced facilitation of hippocampal synaptic transmission in a Tau transgenic model. Aging Cell. 12: 11-23. PMID 23082852 DOI: 10.1111/Acel.12018  0.373
2013 Ando K, Dourlen P, Sambo AV, Bretteville A, Bélarbi K, Vingtdeux V, Eddarkaoui S, Drobecq H, Ghestem A, Bégard S, Demey-Thomas E, Melnyk P, Smet C, Lippens G, Maurage CA, ... ... Hamdane M, et al. Tau pathology modulates Pin1 post-translational modifications and may be relevant as biomarker. Neurobiology of Aging. 34: 757-69. PMID 22926167 DOI: 10.1016/J.Neurobiolaging.2012.08.004  0.502
2012 Burnouf S, Belarbi K, Troquier L, Derisbourg M, Demeyer D, Leboucher A, Laurent C, Hamdane M, Buee L, Blum D. Hippocampal BDNF expression in a tau transgenic mouse model. Current Alzheimer Research. 9: 406-10. PMID 22272617 DOI: 10.2174/156720512800492468  0.453
2011 Belarbi K, Burnouf S, Fernandez-Gomez FJ, Desmercières J, Troquier L, Brouillette J, Tsambou L, Grosjean ME, Caillierez R, Demeyer D, Hamdane M, Schindowski K, Blum D, Buée L. Loss of medial septum cholinergic neurons in THY-Tau22 mouse model: what links with tau pathology? Current Alzheimer Research. 8: 633-8. PMID 21605043 DOI: 10.2174/156720511796717230  0.36
2010 Landrieu I, Leroy A, Smet-Nocca C, Huvent I, Amniai L, Hamdane M, Sibille N, Buée L, Wieruszeski JM, Lippens G. NMR spectroscopy of the neuronal tau protein: normal function and implication in Alzheimer's disease. Biochemical Society Transactions. 38: 1006-11. PMID 20658994 DOI: 10.1042/Bst0381006  0.701
2010 Buée L, Troquier L, Burnouf S, Belarbi K, Van der Jeugd A, Ahmed T, Fernandez-Gomez F, Caillierez R, Grosjean ME, Begard S, Barbot B, Demeyer D, Obriot H, Brion I, Buée-Scherrer V, ... ... Hamdane M, et al. From tau phosphorylation to tau aggregation: what about neuronal death? Biochemical Society Transactions. 38: 967-72. PMID 20658986 DOI: 10.1042/Bst0380967  0.434
2009 Belarbi K, Schindowski K, Burnouf S, Caillierez R, Grosjean ME, Demeyer D, Hamdane M, Sergeant N, Blum D, Buée L. Early Tau pathology involving the septo-hippocampal pathway in a Tau transgenic model: relevance to Alzheimer's disease. Current Alzheimer Research. 6: 152-7. PMID 19355850 DOI: 10.2174/156720509787602843  0.473
2009 Bretteville A, Ando K, Ghestem A, Loyens A, Bégard S, Beauvillain JC, Sergeant N, Hamdane M, Buée L. Two-dimensional electrophoresis of tau mutants reveals specific phosphorylation pattern likely linked to early tau conformational changes. Plos One. 4: e4843. PMID 19290042 DOI: 10.1371/Journal.Pone.0004843  0.483
2008 Sergeant N, Bretteville A, Hamdane M, Caillet-Boudin ML, Grognet P, Bombois S, Blum D, Delacourte A, Pasquier F, Vanmechelen E, Schraen-Maschke S, Buée L. Biochemistry of Tau in Alzheimer's disease and related neurological disorders. Expert Review of Proteomics. 5: 207-24. PMID 18466052 DOI: 10.1586/14789450.5.2.207  0.334
2008 Buee L, Belarbi K, Schindowski K, Burnouf S, Grosjean M, Maurage C, Blum D, Sergeant N, Hamdane M. O1-06-06: Tau pathology triggers cell cycle reactivation, neurotrophins imbalance and cholinergic neurodegeneration Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.261  0.355
2008 Galas M, Dourlen P, Ando K, Bégard S, Hamdane M, Buée L. P3-313: Pin1 deregulation in Alzheimer's disease: A role in the aberrant cell cycle re-entry? Alzheimer's & Dementia. 4: T613-T613. DOI: 10.1016/J.Jalz.2008.05.1882  0.359
2007 Dourlen P, Ando K, Hamdane M, Begard S, Buée L, Galas MC. The peptidyl prolyl cis/trans isomerase Pin1 downregulates the Inhibitor of Apoptosis Protein Survivin. Biochimica Et Biophysica Acta. 1773: 1428-37. PMID 17624454 DOI: 10.1016/J.Bbamcr.2007.05.012  0.343
2007 Hamdane M, Buée L. The complex p25/Cdk5 kinase in neurofibrillary degeneration and neuronal death: the missing link to cell cycle. Biotechnology Journal. 2: 967-77. PMID 17571276 DOI: 10.1002/Biot.200700059  0.371
2007 Vingtdeux V, Hamdane M, Loyens A, Gelé P, Drobeck H, Bégard S, Galas MC, Delacourte A, Beauvillain JC, Buée L, Sergeant N. Alkalizing drugs induce accumulation of amyloid precursor protein by-products in luminal vesicles of multivesicular bodies. The Journal of Biological Chemistry. 282: 18197-205. PMID 17468104 DOI: 10.1074/Jbc.M609475200  0.417
2007 Vingtdeux V, Hamdane M, Bégard S, Loyens A, Delacourte A, Beauvillain JC, Buée L, Marambaud P, Sergeant N. Intracellular pH regulates amyloid precursor protein intracellular domain accumulation. Neurobiology of Disease. 25: 686-96. PMID 17207630 DOI: 10.1016/J.Nbd.2006.09.019  0.434
2006 Schindowski K, Bretteville A, Leroy K, Bégard S, Brion JP, Hamdane M, Buée L. Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits. The American Journal of Pathology. 169: 599-616. PMID 16877359 DOI: 10.2353/Ajpath.2006.060002  0.447
2006 Hamdane M, Dourlen P, Bretteville A, Sambo AV, Ferreira S, Ando K, Kerdraon O, Bégard S, Geay L, Lippens G, Sergeant N, Delacourte A, Maurage CA, Galas MC, Buée L. Pin1 allows for differential Tau dephosphorylation in neuronal cells. Molecular and Cellular Neurosciences. 32: 155-60. PMID 16697218 DOI: 10.1016/J.Mcn.2006.03.006  0.485
2006 Galas MC, Dourlen P, Bégard S, Ando K, Blum D, Hamdane M, Buée L. The peptidylprolyl cis/trans-isomerase Pin1 modulates stress-induced dephosphorylation of Tau in neurons. Implication in a pathological mechanism related to Alzheimer disease. The Journal of Biological Chemistry. 281: 19296-304. PMID 16675464 DOI: 10.1074/Jbc.M601849200  0.47
2006 Schindowski K, Bretteville A, Leroy K, Begard S, Brion J, Hamdane M, Buee L. P1-062: Alzheimer’s disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits Alzheimers & Dementia. 2. DOI: 10.1016/J.Jalz.2006.05.437  0.355
2006 Buee L, Bretteville A, Ando K, Dourlen P, Kerdraon O, Begard S, Schindowski K, Maurage C, Galas M, Hamdane M. S3-03-06: Tau phosphorylation, tauopathies, mitosis-related disease Alzheimer's & Dementia. 2: S49-S50. DOI: 10.1016/J.Jalz.2006.05.2336  0.418
2006 Galas M, Dourlen P, Bégard S, Ando K, Hamdane M, Buée L. P3-334: Pin1 modulates oxidative stress-induced dephosphorylation of tau in neurons: Implication of the peptidyl prolyl cis/trans isomerase in a pathological mechanism related to Alzheimer's disease Alzheimer's & Dementia. 2: S473-S473. DOI: 10.1016/J.Jalz.2006.05.1604  0.388
2005 Vingtdeux V, Hamdane M, Gompel M, Bégard S, Drobecq H, Ghestem A, Grosjean ME, Kostanjevecki V, Grognet P, Vanmechelen E, Buée L, Delacourte A, Sergeant N. Phosphorylation of amyloid precursor carboxy-terminal fragments enhances their processing by a gamma-secretase-dependent mechanism. Neurobiology of Disease. 20: 625-37. PMID 15936948 DOI: 10.1016/J.Nbd.2005.05.004  0.448
2005 Delobel P, Leroy O, Hamdane M, Sambo AV, Delacourte A, Buée L. Proteasome inhibition and Tau proteolysis: an unexpected regulation. Febs Letters. 579: 1-5. PMID 15620682 DOI: 10.1016/J.Febslet.2004.11.018  0.506
2003 Delobel P, Mailliot C, Hamdane M, Sambo AV, Bégard S, Violleau A, Delacourte A, Buée L. Stable-tau overexpression in human neuroblastoma cells: an open door for explaining neuronal death in tauopathies. Annals of the New York Academy of Sciences. 1010: 623-34. PMID 15033802 DOI: 10.1196/Annals.1299.115  0.481
2003 Hamdane M, Delobel P, Sambo AV, Smet C, Bégard S, Violleau A, Landrieu I, Delacourte A, Lippens G, Flament S, Buée L. Neurofibrillary degeneration of the Alzheimer-type: an alternate pathway to neuronal apoptosis? Biochemical Pharmacology. 66: 1619-25. PMID 14555242 DOI: 10.1016/S0006-2952(03)00533-1  0.422
2003 Hamdane M, Sambo AV, Delobel P, Bégard S, Violleau A, Delacourte A, Bertrand P, Benavides J, Buée L. Mitotic-like tau phosphorylation by p25-Cdk5 kinase complex. The Journal of Biological Chemistry. 278: 34026-34. PMID 12826674 DOI: 10.1074/Jbc.M302872200  0.394
2002 Hamdane M, Smet C, Sambo AV, Leroy A, Wieruszeski JM, Delobel P, Maurage CA, Ghestem A, Wintjens R, Bégard S, Sergeant N, Delacourte A, Horvath D, Landrieu I, Lippens G, et al. Pin1: a therapeutic target in Alzheimer neurodegeneration. Journal of Molecular Neuroscience : Mn. 19: 275-87. PMID 12540053 DOI: 10.1385/Jmn:19:3:275  0.454
2002 Delobel P, Flament S, Hamdane M, Mailliot C, Sambo AV, Bégard S, Sergeant N, Delacourte A, Vilain JP, Buée L. Abnormal Tau phosphorylation of the Alzheimer-type also occurs during mitosis. Journal of Neurochemistry. 83: 412-20. PMID 12423251 DOI: 10.1046/J.1471-4159.2002.01143.X  0.476
2002 Buée L, Hamdane M, Delobel P, Sambo AV, Bégard S, Ghestem A, Sergeant N, Delacourte A. [Tau story: from frontotemporal dementia to other tauopathies]. Journal De La Sociã©Tã© De Biologie. 196: 103-8. PMID 12134624  0.379
2002 Delobel P, Flament S, Hamdane M, Delacourte A, Vilain JP, Buée L. Modelling Alzheimer-specific abnormal Tau phosphorylation independently of GSK3beta and PKA kinase activities. Febs Letters. 516: 151-5. PMID 11959122 DOI: 10.1016/S0014-5793(02)02525-5  0.473
2002 Delobel P, Flament S, Hamdane M, Jakes R, Rousseau A, Delacourte A, Vilain JP, Goedert M, Buée L. Functional characterization of FTDP-17 tau gene mutations through their effects on Xenopus oocyte maturation. The Journal of Biological Chemistry. 277: 9199-205. PMID 11756436 DOI: 10.1074/Jbc.M107716200  0.3
2002 Buée L, Hamdane M, Delobel P, Sambo A, Bégard S, Ghestem A, Sergeant N, Delacourte A. Tau story : des démences fronto-temporales aux autres tauopathies Biologie Aujourd'Hui. 196: 103-108. DOI: 10.1051/Jbio/2002196010103  0.339
2000 Mailliot C, Bussière T, Hamdane M, Sergeant N, Caillet ML, Delacourte A, Buée L. Pathological tau phenotypes. The weight of mutations, polymorphisms, and differential neuronal vulnerabilities. Annals of the New York Academy of Sciences. 920: 107-14. PMID 11193138 DOI: 10.1111/J.1749-6632.2000.Tb06911.X  0.477
1998 David-Cordonnier M, Hamdane M, Bailly C, D'Halluin JJ-. The DNA binding domain of the human c-Abl tyrosine kinase preferentially binds to DNA sequences containing an AAC motif and to distorted DNA structures. Biochemistry. 37: 6065-6076. PMID 9558345 DOI: 10.1021/Bi973030W  0.633
1998 David-Cordonnier MlØ, Hamdane M, Bailly C, D'Halluin J. Determination Of The Human C-Abl Consensus Dna Binding Site Febs Letters. 424: 177-182. PMID 9539146 DOI: 10.1016/S0014-5793(98)00169-0  0.636
1997 Hamdane M, David-Cordonnier M, D'Halluin JC. Activation of p65 NF-κB protein by p210BCR-ABL in a myeloid cell line (P210BCR-ABL activates p65 NF-κB) Oncogene. 15: 2267-2275. PMID 9393872 DOI: 10.1038/Sj.Onc.1201411  0.63
Show low-probability matches.